Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'

N. Homer, D. S. Grewal, R. G. Mirza, A. T. Lyon, M. K. Gill

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1630-1631
Number of pages2
JournalEye (Basingstoke)
Issue number12
StatePublished - Dec 1 2015

ASJC Scopus subject areas

  • Sensory Systems
  • Ophthalmology

Cite this